Literature DB >> 1892368

High-speed memory scanning in Parkinson's disease: adverse effects of levodopa.

W Poewe1, W Berger, T Benke, L Schelosky.   

Abstract

High-speed memory scanning as assessed by the Sternberg paradigm was studied in 12 nondemented patients with fluctuating Parkinson's disease and 13 age-matched healthy controls. Patients were first assessed before taking their morning dose of levodopa ("off") and again after that dose had produced full clinical effect ("on") after that dose had produced full clinical effect ("on"). Although motor components of the measured choice reaction time were slower in patients when off than in control subjects, memory scanning speed was not different. After levodopa (on), patients' motor time normalized, but cognitive processing speed became significantly slower when compared with previous performance in the off condition and with controls. Contrary to previous concepts of bradyphrenia in patients with Parkinson's disease, these results indicate that dopaminergic stimulation can reduce cognitive processing speed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1892368     DOI: 10.1002/ana.410290616

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  13 in total

Review 1.  The lesion of the rat substantia nigra pars compacta dopaminergic neurons as a model for Parkinson's disease memory disabilities.

Authors:  Claudio Da Cunha; Miriam Elizabeth Mendes Angelucci; Newton S Canteras; Susan Wonnacott; Reinaldo N Takahashi
Journal:  Cell Mol Neurobiol       Date:  2002-06       Impact factor: 5.046

2.  Individual capacity differences predict working memory performance and prefrontal activity following dopamine receptor stimulation.

Authors:  Sasha E B Gibbs; Mark D'Esposito
Journal:  Cogn Affect Behav Neurosci       Date:  2005-06       Impact factor: 3.282

3.  Frontal assessment battery scores and non-motor symptoms in parkinsonian disorders.

Authors:  Roberto Marconi; Angelo Antonini; Paolo Barone; Carlo Colosimo; Tania P Avarello; Edo Bottacchi; Antonino Cannas; Maria G Ceravolo; Roberto Ceravolo; Giulio Cicarelli; Rosa M Gaglio; Luisa Giglia; Francesco Iemolo; Michela Manfredi; Giuseppe Meco; Alessandra Nicoletti; Massimo Pederzoli; Alfredo Petrone; Antonio Pisani; Francesco E Pontieri; Rocco Quatrale; Silvia Ramat; Rossana Scala; Giampiero Volpe; Salvatore Zappulla; Anna Rita Bentivoglio; Fabrizio Stocchi; Giorgio Trianni; Paolo Del Dotto; Danilo De Gaspari; Lucia Grasso; Francesca Morgante; Gabriella Santangelo; Giovanni Fabbrini; Letterio Morgante
Journal:  Neurol Sci       Date:  2011-11-03       Impact factor: 3.307

Review 4.  Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease.

Authors:  J Kulisevsky
Journal:  Drugs Aging       Date:  2000-05       Impact factor: 3.923

5.  Decreased driving ability in people with Parkinson's disease.

Authors:  V M Heikkilä; J Turkka; J Korpelainen; T Kallanranta; H Summala
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-03       Impact factor: 10.154

6.  Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice models early preclinical phase of Parkinson's disease.

Authors:  Rui D S Prediger; Aderbal S Aguiar; Argelia Esperanza Rojas-Mayorquin; Claudia P Figueiredo; Filipe C Matheus; Laure Ginestet; Caroline Chevarin; Elaine Del Bel; Raymond Mongeau; Michel Hamon; Laurence Lanfumey; Rita Raisman-Vozari
Journal:  Neurotox Res       Date:  2009-07-21       Impact factor: 3.911

7.  Apomorphine induced cognitive changes in Parkinson's disease.

Authors:  E Růzicka; J Roth; N Spacková; P Mecír; R Jech
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

8.  Cognitive slowing in Parkinson's disease resolves after practice.

Authors:  D Z Press; D J Mechanic; D Tarsy; D S Manoach
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-11       Impact factor: 10.154

9.  Compensatory neural mechanisms in cognitively unimpaired Parkinson disease.

Authors:  Kathleen L Poston; Sophie YorkWilliams; Kai Zhang; Weidong Cai; David Everling; Fadi M Tayim; Seoni Llanes; Vinod Menon
Journal:  Ann Neurol       Date:  2016-02-10       Impact factor: 10.422

10.  Measuring the Performance of Attention Networks with the Dalhousie Computerized Attention Battery (DalCAB): Methodology and Reliability in Healthy Adults.

Authors:  Stephanie A H Jones; Beverly C Butler; Franziska Kintzel; Anne Johnson; Raymond M Klein; Gail A Eskes
Journal:  Front Psychol       Date:  2016-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.